Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomib-based chemotherapy

Nine pretreated patients aged >19 years with relapsed/refractory acute lymphoblastic leukemia (ALL) were treated with a combination of bortezomib plus chemotherapy before allogeneic hematopoietic stem cell transplantation (allo-HSCT). Eight (88.9%) patients, including two Philadelphia chromosome-...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Junmei, Wang, Chao, Song, Yongping, Liu, Yuzhang, Fang, Baijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472074/
https://www.ncbi.nlm.nih.gov/pubmed/26109875
http://dx.doi.org/10.2147/IJGM.S59537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472074/
https://www.ncbi.nlm.nih.gov/pubmed/26109875
http://dx.doi.org/10.2147/IJGM.S59537

Ejemplares similares